Metformin suppresses calcium oxalate crystal-induced kidney injury by promoting Sirt1 and M2 macrophage-mediated anti-inflammatory activation

Signal Transduct Target Ther. 2023 Jan 27;8(1):38. doi: 10.1038/s41392-022-01232-3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Calcium Oxalate*
  • Kidney
  • Macrophages
  • Metformin* / pharmacology
  • Sirtuin 1 / genetics

Substances

  • Calcium Oxalate
  • Metformin
  • Sirtuin 1
  • Anti-Inflammatory Agents